Huayang Pharmaceutical Excipients is an enterprise with Grade A product filing and registration by the National Medical Products Administration (NMPA), a High-Tech Enterprise of Shandong Province, a member unit of IPEC China (International Pharmaceutical Excipients Council China), and a member unit of the Pharmaceutical Chamber of All-China Federation of Industry and Commerce. The company is located in the Biopharmaceutical Park of Liaocheng High-Tech Zone, a scenic "Water City in Northern China". Founded in January 2010 with a registered capital of 15 million yuan, it covers an area of 20,000 square meters and currently has 58 employees, including more than 10 professionals with bachelor's degrees and senior industry technical expertise. All production lines, inspection equipment and facilities are designed and constructed in accordance with GMP standards, and the whole production process has basically realized semi-automated production technology.
The company's main products include corn starch, soluble starch, pregelatinized starch, tapioca starch, potato starch, dextrin, maltodextrin, etc. Since its establishment, the company has accumulated more than 10 years of production and technical experience, owned 6 invention patents and 12 utility model patents, and has passed ISO 9001 Quality Management System Certification and ISO 14001 Environmental Management System Certification. The product advantages are concentrated in meeting the diverse needs of customers, and have been widely praised and recognized by customers such as Jianmin Pharmaceutical Group, CSPC Pharmaceutical Group, Jichuan Pharmaceutical Group, Xinbang Pharmaceutical, and North China Pharmaceutical.
We adhere to the business principles of "market-oriented, sales-led, R&D innovation-supported, production-centered, and finance & management-guaranteed"; uphold the business guidelines of "customer first, data-based, result-oriented, and continuous improvement"; adhere to the business philosophy of "integrity-based, pioneering and innovative, and win-win cooperation"; and adhere to the management philosophy of "people-oriented, incentive-driven, and common development".
We adhere to the business strategy of differentiated competition. Our products are positioned for market customers with diverse functional requirements or special demands for pharmaceutical excipients. We focus on the high-end market, increase the proportion of such products in our product structure, and refrain from vicious competition in low-end generic products. We continuously commit to seizing differentiated competition opportunities in the pharmaceutical excipient industry to enhance the company's profitability and operational capabilities. We strive to become a well-known enterprise in the pharmaceutical excipient industry and achieve listing on the ChiNext Market within five years.
We will continue to adhere to market orientation, pursue development driven by the dual engines of sustained scientific research innovation and management innovation, and uphold the core corporate values of "Integrity, Competition, Service, Innovation, Optimism, and Sharing". We are committed to building the largest pharmaceutical excipient production base in East China and a key leading enterprise of pharmaceutical excipients in China, and will always adhere to our corporate mission of "being the most sincere and professional long-term partner for Chinese pharmaceutical enterprises"!
